Octapharma AG - Press Release & Archive 
EN: Navigation mit Access Keys
- [Alt + 0] - Startseite
- [Alt + 1] - Navigation
- [Alt + 2] - Inhalt
- [Alt + 3] - Kontakt
- [Alt + 4] - Sitemap
- [Alt + 5] - Suche
Octapharma - always up to date
EN: Hauptnavigation
Press Release & Archive
News
Octapharma Group releases 2011 Annual Report
30.03.2012
2011 has been a successful transitional year for the Octapharma Group. Since octagam® 5% and 10% re-entered all important markets profitability experienced a month-by-month continuous improvement. Re-entry combined with the...
Octapharma USA Submits BLA for octaplasLG®, A Therapy Targeting Adverse Transfusion Events
28.02.2012
Product Features Solvent/Detergent Inactivation Against Enveloped Viruses and Immune Neutralization Against Non-Enveloped Viruses
Octapharma USA appoints David E. Holliday as Vice President of Commercial Development
12.01.2012
HOBOKEN, N.J. (January 11, 2012) – Octapharma USA today announced that David E. Holliday has joined the biopharmaceutical company as Vice President of Commercial Development, assuming immediate responsibility for all U.S....